SB
CLSD

Suntrust Banks’s Clearside Biomedical CLSD Stock Holding History

Suntrust Banks’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-887
Closed -$116K – 1246
2017
Q3 		$116K Hold
887
– – ﹤0.01% 1237
2017
Q2 		$121K Hold
887
– – ﹤0.01% 1226
2017
Q1 		$106K Hold
887
– – ﹤0.01% 1226
2016
Q4 		$118K Hold
887
– – ﹤0.01% 1530
2016
Q3 		$230K Hold
887
– – ﹤0.01% 1358
2016
Q2 		$93K Buy
+887
New +$93K ﹤0.01% 1469

Other funds holding CLSD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Suntrust Banks's CLSD Position: Q4 2017 in Review

Suntrust Banks sold out of Clearside Biomedical (CLSD) in Q4 2017, closing a stake of 887 shares — an estimated $116K sold.

Suntrust Banks first reported a position in CLSD in Q2 2016 and held it in 6 quarters. The position peaked at $230K in Q3 2016. 54 funds tracked by Wall St. Rank hold CLSD as of Q4 2017.

  • Suntrust Banks reported no remaining Clearside Biomedical position as of Q4 2017 after selling out during the quarter.
  • Suntrust Banks sold 887 Clearside Biomedical shares in Q4 2017, an estimated $116K.
  • Suntrust Banks first reported a position in Clearside Biomedical in Q2 2016 and held it in 6 quarters.
  • Suntrust Banks's Clearside Biomedical position peaked at $230K in Q3 2016.
  • 54 funds tracked by Wall St. Rank held Clearside Biomedical as of Q4 2017.

Based on Suntrust Banks's 13F filing for Q4 2017, filed 9 Feb 2018.